Sophie Morse is a Hematologist Oncology specialist and a Hematologist in Summit, New Jersey. Dr. Morse is rated as a Distinguished provider by MediFind in the treatment of Familial Pancreatic Cancer. Her top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Familial Pancreatic Cancer.

Usman Shah is a Hematologist and an Oncologist in Summit, New Jersey. Dr. Shah is rated as a Distinguished provider by MediFind in the treatment of Familial Pancreatic Cancer. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Shah is currently accepting new patients.

Hazar Michael is a Gastroenterologist in Berkeley Heights, New Jersey. Dr. Michael is rated as a Distinguished provider by MediFind in the treatment of Familial Pancreatic Cancer. Her top areas of expertise are Bile Duct Obstruction, Pancreatic Cancer, Familial Pancreatic Cancer, Gastrectomy, and Endoscopy. Dr. Michael is currently accepting new patients.

Tamir Menachem is a Gastroenterologist in Berkeley Heights, New Jersey. Dr. Menachem is rated as a Distinguished provider by MediFind in the treatment of Familial Pancreatic Cancer. His top areas of expertise are Bile Duct Obstruction, Bile Duct Stricture, Cholestasis, Endoscopy, and Pancreatectomy. Dr. Menachem is currently accepting new patients.

Joana S. Emmolo, MD is a board certified radiation oncologist at Atlantic Health System's Overlook Medical Center and CyberKnife Center. She is a member of various tumor boards for the Carol G. Simon Cancer Center and The Gerald J. Glasser Brain Tumor Center. Dr. Emmolo has a focus on brain tumors and breast cancer, with a special interest in accelerated and minimally invasive treatment options for both disease sites. She attended the University of Medicine and Dentistry of New Jersey in Newark, NJ and served as Chief Resident at New York Methodist Hospital in Brooklyn, NY. Dr. Emmolo speaks Spanish and Italian. In her free time, Dr. Emmolo enjoys spending time with her two young boys and travelling with family. Dr. Emmolo is rated as an Advanced provider by MediFind in the treatment of Familial Pancreatic Cancer. Her top areas of expertise are Radiation Induced Meningioma, Posterior Fossa Tumor, Meningioma, and Pleuropulmonary Blastoma.

Joshua A. Strauss, MD, is a hematologist-oncologist with Advanced Care Oncology and Hematology Associates (ACOHA), part of the Atlantic Medical Group (AMG). He is fellowship-trained and double-board-certified in medical oncology and hematology by the American Board of Internal Medicine. He has more than 15 years of experience taking care of patients with a variety of malignancies and blood disorders. Dr. Strauss especially takes pride in treating his patients with compassion and going the extra mile to deliver the highest quality of care.Dr. Strauss strives to incorporate the most up-to-date knowledge in the field with an approach geared to the needs of each individual patient. He maintains clinical interests in gastrointestinal, urologic and gynecologic cancers, as well as leukemia, lymphoma and benign blood disorders. Dr. Strauss joined ACOHA in 2015.After earning his medical degree at the Albert Einstein College of Medicine in the Bronx, where he graduated with special distinction for research in medical oncology, Dr. Strauss completed his residency in internal medicine at New York University Langone Medical Center. He then completed fellowship training in hematology/oncology at New York-Presbyterian/Columbia University Medical Center, also in NYC, where he participated in high-level research and published several peer-reviewed articles in gastrointestinal cancer.Dr. Strauss has been voted by physician colleagues as a “Top Doctor” in New Jersey Monthly magazine every year since 2020. He is a member of the American Society of Clinical Oncology and the American Society of Hematology, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Strauss is rated as an Advanced provider by MediFind in the treatment of Familial Pancreatic Cancer. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Myelodysplastic Syndrome (MDS), Colorectal Cancer, and Bone Marrow Aspiration.

David Rahni is a Gastroenterologist in West Orange, New Jersey. Dr. Rahni is rated as an Advanced provider by MediFind in the treatment of Familial Pancreatic Cancer. His top areas of expertise are Acute Pancreatitis, Pancreatic Cancer, Familial Pancreatic Cancer, Endoscopy, and Colonoscopy. Dr. Rahni is currently accepting new patients.

Dhanasekaran Ramasamy is a Gastroenterologist in Union, New Jersey. Dr. Ramasamy is rated as an Advanced provider by MediFind in the treatment of Familial Pancreatic Cancer. His top areas of expertise are Choledocholithiasis, Bile Duct Obstruction, Gas Bloat Syndrome, Gastrectomy, and Endoscopy. Dr. Ramasamy is currently accepting new patients.

Larry Siu is a Gastroenterologist in Morristown, New Jersey. Dr. Siu is rated as a Distinguished provider by MediFind in the treatment of Familial Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Choledocholithiasis, Familial Pancreatic Cancer, Endoscopy, and Gastrectomy. Dr. Siu is currently accepting new patients.

"Dr. Angela Alistar is a board-certified medical oncologist with Atlantic Hematology Oncology, Atlantic Medical Group. Dr. Alistar is Medical Director of GI Medical Oncology at Morristown Medical Center where she is also Medical Director of the phase 1 Breakthrough Treatment Center. Her research focus is related to immuno-oncology and cancer metabolism in gastrointestinal cancer such as: pancreatic tumors, cholangiocarcinoma, colorectal, esophageal, gastric cancer and hepatocellular carcinoma. Her clinical research projects involve active collaborative efforts with other medical departments, such as radiation oncology and surgical oncology, as well as genomics and cancer biology.Recently, she published in Lancet Oncology the results of a Phase I clinical study in pancreatic cancer that are very promising for advancing the field for this disease. This study has shown impressive synergy of a novel agent, CPI -613 in combination with chemotherapy. She is co-leading the national multi-site, randomized study of this promising combination, as well as many other phase 1-3 clinical trials.Dr. Alistar comes to Atlantic Health System from Wake Forest School of Medicine where she had a heavy emphasis on clinical trials and clinical research. At Wake Forest, she led the GI oncology disease oriented team as a gastrointestinal medical oncology physician and researcher, bringing cutting-edge treatments to patients. She designed, secured funding for and conducted five investigator-initiated therapeutic clinical trials, with four of them being phase one. Her work involved maintenance of a sponsor-investigator investigational new drug. She is passionate about Precision Oncology and Immunotherapies and seeks to identify novel treatment strategies for her patients.Past positions at Wake Forest include being a member of the Translational Cancer Genomics Committee, the GI Tumor Board, Internal Medicine Grand Rounds, and the Hepatobiliary Oncology Committee. She is a member of several health care organizations, such as the American Society of Clinical Oncology, the American Society of Hospice and Palliative Care Medicine, and the American Society of Hematology, among many others. As well, she is a member and advisor for several other health care institutions. She was recently awarded the ""Danny Danielson Translational Innovation Award"" by Hoosier Cancer Research Network for her commitment to clinical research. Dr. Alistar received her medical degree from University of Medicine and Pharmacy, Cluj Napoca, Romania and her residency at Englewood Hospital and Medical Center, NJ, where she was chief resident. After her residency, she completed hematology oncology fellowship at Mount Sinai School of Medicine, Tisch Cancer Institute. She is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization, and sees patients at Morristown Medical Center.". Dr. Alistar is rated as a Distinguished provider by MediFind in the treatment of Familial Pancreatic Cancer. Her top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, and Stomach Cancer.

Dr. Kai Bickenbach provides cancer patients with exceptional surgical care at Atlantic Surgical Oncology. His areas of specialty include melanoma, sarcoma, pancreatic cancer, liver and biliary cancer, esophageal and gastric cancer and colorectal cancer. He is trained in the use of many novel therapies, including the NanoKnife® to treat un-resectable pancreatic and liver tumors, as well as hepatic arterial infusion pumps. Dr. Bickenbach and his partners are fellowship trained surgical oncologists providing patients the latest in surgical innovation and clinical research options. Atlantic Surgical Oncology Associates work closely with medical oncology, radiation oncology and other specialists in a multidisciplinary fashion on two campuses of the Carol G. Simon Cancer Center at Morristown Medical Center and Overlook Medical Center in Summit. Dr. Bickenbach is a member of a variety of medical organizations including the American College of Surgeons, the Society of Surgical Oncology, the American Society of Clinical Oncology, and the Americas Hepato-Pancreatico-Biliary Association, and is a councilman for the New Jersey Chapter of the American College of Surgeons. He is widely published and has presented at national meetings on cancer related topics.After graduating from Wayne State University School of Medicine in 2002, Dr. Bickenbach completed his surgical residency at the University of Chicago Medical Center in 2009, where he was elected administrative chief resident. During that time, Dr. Bickenbach completed a two-year research fellowship, focusing on the use of oncolytic viruses in the treatment of cancer. Following residency, Dr. Bickenbach completed a fellowship in Surgical Oncology at Memorial Sloan-Kettering Cancer Center. He sees patients at Morristown, Overlook, Newton, Chilton and Hackettstown medical centers. He is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization. Dr. Bickenbach is rated as a Distinguished provider by MediFind in the treatment of Familial Pancreatic Cancer. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Small Bowel Resection, and Pancreatectomy.

Dr. Michael Scola is a board-certified, fellowship-trained hematologist oncologist practicing at Atlantic Hematology Oncology located at Morristown Medical Center. For the past 20 years, Dr. Scola has maintained a broad-based clinical practice, with a focus on benign and malignant hematology. He is currently director of the new Atlantic Thrombosis Center, designed to investigate and manage patients with a variety of bleeding and clotting disorders. Dr. Scola is a skilled and compassionate physician. His postdoctoral training includes a fellowship in hematology oncology from Boston University Medical Center, where he received the Outstanding Fellow award and the Chiefs’ Hematology Award for clinical excellence. He received his medical degree from Baylor College of Medicine in Houston, TX. A teacher and mentor, Dr. Scola served many years as course director of pathophysiology at Northeastern University, Boston, and is actively involved in instructing residents at Morristown Medical Center. He is also involved in clinical research; has worked within the industry as a consultant, lecturer and advisor; and has authored articles and book chapters. Dr. Scola’s education includes a year spent abroad in Florence, Italy, and an intensive post-training program in clinical research at the Harvard School of Public Health. He serves on the boards of the Cancer Hope Network, and the Cancer Support Community of Central New Jersey. Dr. Scola is a member of the American Society of Hematology, American Society of Clinical Oncology and the International Society of Thrombosis and Hemostasis. Dr. Scola is rated as a Distinguished provider by MediFind in the treatment of Familial Pancreatic Cancer. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Non-Hodgkin Lymphoma, Anemia, and Bone Marrow Aspiration.

Lee Starker, MD, PhD, is a medical director of surgical oncology for the eastern region with a special interest in thyroid and parathyroid tumors and cancers, endocrine disorders, melanoma, hormones and metabolism, and cancer genetics. He is highly trained in pancreatic and complex hepatobiliary surgery. He also specializes in NanoKnife® to treat unresectable pancreatic and liver cancers as well as hyperthermic intraperitoneal chemotherapy (HIPEC), which is a highly concentrated, heated chemotherapy treatment delivered directly to the abdomen during surgery for peritoneal malignancies.After completing his surgical residency at Yale New Haven Hospital in Connecticut and surgical oncology fellowship training at MD Anderson Cancer Center in Texas, Dr. Starker returned to his New Jersey roots. Prior to that, he earned a PhD in epigenetics and genetics of parathyroid tumors from Uppsala University in Sweden, where he was chief resident and fellow. While studying there, he received the Gold Humanism Award, which recognizes excellence in clinical care, leadership, compassion and dedication to service. He has also been named an NJ Top Doctor annually by NJ Monthly Magazine.Dr. Starker is widely published in various medical journals, including the World Journal of Oncology and International Journal of Endocrinology. He is a member of the Society of Surgical Oncology. Dr. Starker and his partners provide patients with the latest surgical innovations and clinical research options. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Starker is rated as a Distinguished provider by MediFind in the treatment of Familial Pancreatic Cancer. His top areas of expertise are Familial Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Small Bowel Resection, and Pancreatectomy.

Lawrence Harrison, MD, is chief of Atlantic Surgical Oncology, which provides expert care across a broad spectrum of cancers, focusing on hepatobiliary, pancreatic, colorectal, gastroesophageal, skin and soft tissue cancers. As fellowship-trained surgical oncologists, Dr. Harrison and his partners provide patients with the latest in surgical innovations and clinical research options. Atlantic Surgical Oncology works closely with medical oncology, radiation oncology and other specialists in a multidisciplinary fashion on two campuses of the Carol G. Simon Cancer Center at Morristown Medical Center and at Overlook Medical Center in Summit. Dr. Harrison has been a surgical innovator since finishing fellowship training at Memorial Sloan Kettering Cancer Center in New York City. He has extensive training in novel surgical techniques, including in hyperthermic intraperitoneal chemotherapy (HIPEC), which is a highly concentrated, heated chemotherapy treatment delivered directly to the abdomen during surgery. Prior to joining Atlantic Surgical Oncology, Dr. Harrison served as director of surgical oncology at Valley Hospital in Ridgewood where he developed expertise in robotic surgery, performing more than 200 complex robotic surgical procedures. He also was director of the Advanced Gastrointestinal Surgical Fellowship. Previously, Dr. Harrison was associate professor of surgery and chief of the Division of Surgical Oncology at University Hospital in Newark for 12 years. In addition to his clinical practice, he was involved in research and taught medical residents and students. He is a fellow of the American College of Surgeons. Dr. Harrison sees patients at Morristown and Overlook medicals centers, and provides consultative services to Newton, Chilton and Hackettstown medical centers. Dr. Harrison is rated as a Distinguished provider by MediFind in the treatment of Familial Pancreatic Cancer. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.

Yousaf Mahmood is an Interventional Radiologist in Summit, New Jersey. Dr. Mahmood is rated as an Advanced provider by MediFind in the treatment of Familial Pancreatic Cancer. His top areas of expertise are Familial Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Bone Marrow Aspiration, and Gastrostomy.

Dr. Amish Patel is an interventional radiologist with Atlantic Medical Group Radiology, specializing in image-guided procedures. Fellowship-trained and board certified in vascular and interventional radiology, Dr. Patel performs minimally invasive procedures that often replace major surgery, achieving the same results with fewer complications and speedier recovery time.With skillful precision and using the latest techniques, Dr. Patel offers a wide range of procedures targeting different parts of the body. In addition to active research trials, book chapters, and guest lectures both nationally and internationally, he serves on several committees with the Society of Interventional Radiology. Dr. Patel is committed to fostering the development and enhancement of innovative, image-guided therapies to improve patient care and quality of life. He is a diplomate of the American Board of Radiology.Prior to joining Atlantic Medical Group Radiology, Dr. Patel was an assistant professor of radiology at NYU Langone Health where he served as director of Quality and Safety for Interventional Radiology. He is service-oriented and strives to make the referral and treatment process seamless for both the patient and the referring physician.Dr. Patel is a participating provider of the Atlantic Accountable Care Organization. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Familial Pancreatic Cancer. His top areas of expertise are Ascites, Gallbladder Disease, Liver Cancer, Liver Embolization, and Gastrostomy.

Dr. Dennis Lowenthal has dedicated his career to caring for cancer patients, particularly those with lung cancer. He is the medical director of Medical Diagnostics Associates Hematology and Oncology, which is part of the Atlantic Medical Group. He also serves as medical director of Atlantic Health System’s Carol G. Simon Cancer Center at Overlook Medical Center.Growing up in the Bronx, NY, Dr. Lowenthal attended the State University of New York at Buffalo where he graduated magna cum laude with a BA in biology. He earned his medical degree at Boston University School of Medicine, continued with a medical internship at the Cleveland Clinic, and returned to the Bronx to complete his medical residency and a hematology fellowship at Montefiore Hospital and Medical Center of the Albert Einstein College of Medicine. He subsequently completed a clinical Blood Bank Directors fellowship at the New York Blood Center and then went on to complete a medical oncology fellowship at Memorial Sloan-Kettering Cancer Center where he served as Chief Fellow and Special Clinical Fellow in AIDS-related malignancies.Dr. Lowenthal considers coming to Overlook Medical Center 32 years ago one of his best life decisions, working with his colleagues to help create the Carol G. Simon Cancer Center at Overlook Medical Center. He serves as chairman of the hospital’s Cancer Committee and Cancer Center Executive Committee, and has been the long-standing section chief for Hematology/Oncology. He is co-chairman of Thoracic Oncology and the Thoracic Tumor Board at Atlantic Health System and is the principal investigator for lung cancer clinical trials conducted at Overlook Medical Center – specifically, serving as the principal investigator for the first immunotherapy approved for the treatment of lung cancer. Dr. Lowenthal is a past recipient of Overlook’s Physician Excellence in Clinical Practice award and has been an associate professor of Clinical Medicine at Columbia University College of Physicians and Surgeons, Mount Sinai School of Medicine, and currently the Sidney Kimmel Medical College at Thomas Jefferson University. Dr. Lowenthal is rated as an Experienced provider by MediFind in the treatment of Familial Pancreatic Cancer. His top areas of expertise are Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, and ALK-Positive Non-Small Cell Lung Cancer.

Vyacheslav Gendel is a Radiologist and an Interventional Radiologist in Summit, New Jersey. Dr. Gendel is rated as an Experienced provider by MediFind in the treatment of Familial Pancreatic Cancer. His top areas of expertise are Pleurisy, Pleural Effusion, Secondary Peritonitis, Bone Marrow Aspiration, and Gastrostomy. Dr. Gendel is currently accepting new patients.

Nikhil Jain is an Interventional Radiologist in Summit, New Jersey. Dr. Jain is rated as an Experienced provider by MediFind in the treatment of Familial Pancreatic Cancer. His top areas of expertise are Pleurisy, Hepatocerebral Degeneration, Pleural Effusion, Bone Graft, and Vertebroplasty. Dr. Jain is currently accepting new patients.

Matthew Stuart, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Dr. Stuart’s clinical interests include colorectal, pancreatic, gastrointestinal, lung, urological (GU) cancer, hematology, anemia, clotting disorders, lymphoma, multiple myeloma, and preventative care.Board-certified in internal medicine, medical oncology and hematology by the American Board of Internal Medicine, Dr. Stuart believes in treating the patient as a whole, implementing evidence-based, patient-centered, and cost-conscious care. His recent research includes evaluating race-based differences in treatment complications in patients with metastatic prostate cancer, improving vaccination rates in patients receiving chemotherapy, and providing community outreach to increase lung cancer screening and early detection.Dr. Stuart earned his medical degree at Rutgers New Jersey Medical School, Newark, NJ, where he served as director of the Student Family Health Care Center, the mini-medical school and premedical honors program, and the Institute for Public Understanding of Medicine in Action. He performed his internal medicine residency at Montefiore Medical Center, Bronx, NY, where he served on the Emergency-Internal Medicine and Resident Recruitment committees and received the Leo M. Davidoff Society Award for outstanding achievement in the teaching of medical students and a program innovation and improvement award. He remained at Montefiore to complete a fellowship in hematology/oncology, where he was named the chief hematology fellow and served on the Program Evaluation Committee. Following his fellowship training, he joined ACOHA in 2020.Fluent in conversational Spanish, Dr Stuart has presented at national and international medical conferences. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Stuart is rated as an Experienced provider by MediFind in the treatment of Familial Pancreatic Cancer. His top areas of expertise are Childhood Iron Deficiency Anemia, Familial Colorectal Cancer, Colorectal Cancer, Iron Deficiency Anemia, and Bone Marrow Aspiration.